111 related articles for article (PubMed ID: 38479721)
1. Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2.
Chen Y; Liu J; Zhang Q; Chai L; Chen H; Li D; Wang Y; Qiu Y; Shen N; Zhang J; Wang Q; Wang J; Xie X; Li S; Li M
Eur J Pharmacol; 2024 May; 970():176483. PubMed ID: 38479721
[TBL] [Abstract][Full Text] [Related]
2. alpha1A-adrenoceptor is involved in norepinephrine-induced proliferation of pulmonary artery smooth muscle cells via CaMKII signaling.
Luo Q; Wang X; Liu R; Qiao H; Wang P; Jiang C; Zhang Q; Cao Y; Yu H; Qu L
J Cell Biochem; 2019 Jun; 120(6):9345-9355. PubMed ID: 30520144
[TBL] [Abstract][Full Text] [Related]
3. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1α and Runx2.
Chi PL; Cheng CC; Wang MT; Liao JB; Kuo SH; Lin KC; Shen MC; Huang WC
Cardiovasc Res; 2024 Mar; 120(2):203-214. PubMed ID: 38252891
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
7. Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling.
Kawade A; Yamamura A; Kondo R; Suzuki Y; Yamamura H
J Pharmacol Sci; 2023 Feb; 151(2):119-127. PubMed ID: 36707177
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
9. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
Yamamura A; Nayeem MJ; Sato M
Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
[TBL] [Abstract][Full Text] [Related]
10. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
11. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
[TBL] [Abstract][Full Text] [Related]
12. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
[TBL] [Abstract][Full Text] [Related]
13. Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.
Ruffenach G; Chabot S; Tanguay VF; Courboulin A; Boucherat O; Potus F; Meloche J; Pflieger A; Breuils-Bonnet S; Nadeau V; Paradis R; Tremblay E; Girerd B; Hautefort A; Montani D; Fadel E; Dorfmuller P; Humbert M; Perros F; Paulin R; Provencher S; Bonnet S
Am J Respir Crit Care Med; 2016 Nov; 194(10):1273-1285. PubMed ID: 27149112
[TBL] [Abstract][Full Text] [Related]
14. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
[TBL] [Abstract][Full Text] [Related]
15. PDGF/MEK/ERK axis represses Ca
Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
[TBL] [Abstract][Full Text] [Related]
16. CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFκB pathway in pulmonary arterial hypertension.
Yan X; Huang J; Zeng Y; Zhong X; Fu Y; Xiao H; Wang X; Lian H; Luo H; Li D; Guo R
Biochem Pharmacol; 2024 Apr; 222():116093. PubMed ID: 38408681
[TBL] [Abstract][Full Text] [Related]
17. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
[TBL] [Abstract][Full Text] [Related]
18. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
19. PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
Kovacs L; Cao Y; Han W; Meadows L; Kovacs-Kasa A; Kondrikov D; Verin AD; Barman SA; Dong Z; Huo Y; Su Y
Am J Respir Crit Care Med; 2019 Sep; 200(5):617-627. PubMed ID: 30817168
[No Abstract] [Full Text] [Related]
20. Induction of GLI1 by miR-27b-3p/FBXW7/KLF5 pathway contributes to pulmonary arterial hypertension.
Wang Q; Chai L; Zhang Q; Wang J; Liu J; Chen H; Wang Y; Chen Y; Shen N; Xie X; Li M
J Mol Cell Cardiol; 2022 Oct; 171():16-29. PubMed ID: 35810662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
